Drug · DIN 02248240
ELIGARD
3-MONTH. SINGLE-DOSE PREFILLED SYRINGES
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 25, 2022; first marketed December 1, 2003.
- Drug Identification Number (DIN)
- 02248240
- Company (DIN owner)
- Tolmar International Ltd.Dublin, Dublin, Ireland
- Schedule
- Prescription
- Dosage form
- Powder For Suspension (Sustained-Release
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Leuprorelin L02AE02
- Class
- Human
- Record last updated
- August 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEUPROLIDE ACETATE | 22.5 MG | SYR |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 29, 2021: NOC 27309New Drug Submission (NDS) · Administrative: Change in Product Ownership
- March 29, 2006: NOC 7850New Drug Submission (NDS) · Manufacturer name change
- November 6, 2003: NOC 1534New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “eligard”. A notice may cover another product or only some lots: read it to see what it covers.
- ELIGARD 7.5mg: may not be filled with correct amount of leuprolide acetate.September 12, 2023 · Drugs · Product quality · Type II
Other DINs named ELIGARD
- DIN 02248239 · Marketed
- DIN 02248999 · Marketed
- DIN 02268892 · Marketed